The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease.

@article{Gosselin2009TheIO,
  title={The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease.},
  author={Antoine Gosselin and Roger Luo and Herve Lohoues and Edmond L Toy and Barbara Edelman Lewis and Joseph A. Crawley and Mei Sheng Duh},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2009},
  volume={12 1},
  pages={34-9}
}
OBJECTIVE Standard pharmacotherapy for patients with gastroesophageal reflux disease (GERD) includes treatment with proton pump inhibitors (PPIs). This study examined the effect of GERD patients' compliance with PPI therapy on health-care resource utilization and costs. METHODS This was a retrospective study of more than 25 million managed care lives in the United States from January 2000 through February 2005. Administrative claims data were obtained from the National Managed Care Benchmarks… CONTINUE READING